This grant is for Early Stage Investigators to conduct preclinical HIV/AIDS research utilizing Nonhuman Primate (NHP) models. It supports researchers within 10 years of their terminal degree/residency and at least two years postdoctoral experience. The aim is to grant independence, allowing them to develop new research directions and enhance competitiveness for future project funding. Research must focus on HIV/AIDS translational studies using NHPs, encompassing objectives like prevention, cure, next-generation therapies, and understanding comorbidities/complications. This initiative aligns with strategic goals to advance HIV/AIDS research.
Opportunity ID: 327727
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-20-212 |
| Funding Opportunity Title: | Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 16, 2020 |
| Last Updated Date: | Jun 16, 2020 |
| Original Closing Date for Applications: | Sep 07, 2022 |
| Current Closing Date for Applications: | Sep 07, 2022 |
| Archive Date: | Oct 13, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments State governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Small businesses Public and State controlled institutions of higher education Independent school districts For profit organizations other than small businesses Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding announcement is to support preclinical HIV/AIDS research using NHP models performed by Early Stage Investigators who are within 10 years of their terminal degree or residency training but who have at least two years of postdoctoral experience. The goal of this support is to help advance HIV/AIDS researchers using NHP models in preclinical research by providing a degree of independence for these Early Stage Investigators to develop new research directions and to position these researchers to be competitive for new research project (e.g., R01) funding. Research must be in the field of HIV/AIDS translational studies, using NHPs as preclinical models. This funding initiative encompasses all objectives of the fiscal year (FY) 2019/2020 NIH strategic plan for HIV and HIV-Related Research (https://www.oar.nih.gov/hiv-policy-and-research/strategic-plan), including research directed towards prevention and cure of HIV infection; next-generation therapies; understanding the roles of comorbidities, coinfections and complications; and cross-cutting activities such as building capacity. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-212.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 327727 Full Announcement-PAR-20-212 -> PAR-20-212-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00262225 | Aug 07, 2020 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270276 | Nov 16, 2021 | Sep 07, 2022 | View |
Package 1
Mandatory forms
327727 RR_SF424_2_0-2.0.pdf
327727 PHS398_CoverPageSupplement_5_0-5.0.pdf
327727 RR_OtherProjectInfo_1_4-1.4.pdf
327727 PerformanceSite_2_0-2.0.pdf
327727 RR_KeyPersonExpanded_2_0-2.0.pdf
327727 PHS398_ResearchPlan_4_0-4.0.pdf
327727 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
327727 RR_Budget_1_4-1.4.pdf
327727 RR_SubawardBudget30_1_4-1.4.pdf
327727 PHS398_ModularBudget_1_2-1.2.pdf
327727 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
327727 RR_SF424_5_0-5.0.pdf
327727 PHS398_CoverPageSupplement_5_0-5.0.pdf
327727 RR_OtherProjectInfo_1_4-1.4.pdf
327727 PerformanceSite_4_0-4.0.pdf
327727 RR_KeyPersonExpanded_4_0-4.0.pdf
327727 PHS398_ResearchPlan_4_0-4.0.pdf
327727 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
327727 RR_Budget_3_0-3.0.pdf
327727 RR_SubawardBudget30_3_0-3.0.pdf
327727 PHS398_ModularBudget_1_2-1.2.pdf
327727 PHS_AssignmentRequestForm_3_0-3.0.pdf